BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12597298)

  • 1. Glycogenosis type VII (Tarui's disease): diagnostic considerations and late sequelae.
    Ronquist G
    South Med J; 2002 Dec; 95(12):1361-2. PubMed ID: 12597298
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive mitral valve thickening and progressive muscle cramps as manifestations of glycogenosis VII (Tarui's Disease).
    Finsterer J; Stöllberger C
    Cardiology; 2008; 110(4):238-40. PubMed ID: 18073478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Exercise-induced muscle pain due to phosphofrutokinase deficiency: Diagnostic contribution of metabolic explorations (exercise tests, 31P-nuclear magnetic resonance spectroscopy)].
    Drouet A; Zagnoli F; Fassier T; Rannou F; Baverel F; Piraud M; Bahuau M; Petit F; Streichenberger N; Marcorelles P; Vital Durand D
    Rev Neurol (Paris); 2013; 169(8-9):613-24. PubMed ID: 24011984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle phosphofructokinase deficiency (Tarui's disease): report of a case.
    Lin HC; Young C; Wang PJ; Shen YZ
    J Formos Med Assoc; 1999 Mar; 98(3):205-8. PubMed ID: 10365541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glycogenosis type VII (glycogen storage disease type VII, human muscle-phosphofructokinase deficiency, Tarui's disease)].
    Yamasaki T; Nakajima H
    Ryoikibetsu Shokogun Shirizu; 2001; (36):28-34. PubMed ID: 11596390
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver glycogenosis and cataracts in a mentally deficient child.
    de Loore I; van Gelderen HH
    Arch Dis Child; 1967 Aug; 42(224):435-40. PubMed ID: 4951643
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contribution of Japanese researchers to the progress of studies in endocrinology and metabolism in the field of internal medicine in the last 100 years: Tarui's disease(muscular phosphofructokinase deficiency)].
    Tarui S
    Nihon Naika Gakkai Zasshi; 2002 Apr; 91(4):1145-8. PubMed ID: 12056008
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurologic and cardiac progression of glycogenosis type VII over an eight-year period.
    Finsterer J; Stöllberger C; Kopsa W
    South Med J; 2002 Dec; 95(12):1436-40. PubMed ID: 12597313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Various classes of mutations in patients with phosphofructokinase deficiency (Tarui's disease).
    Raben N; Sherman JB; Adams E; Nakajima H; Argov Z; Plotz P
    Muscle Nerve Suppl; 1995; 3():S35-8. PubMed ID: 7603525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile-onset permanent weakness in muscle phosphofructokinase deficiency.
    Malfatti E; Birouk N; Romero NB; Piraud M; Petit FM; Hogrel JY; Laforêt P
    J Neurol Sci; 2012 May; 316(1-2):173-7. PubMed ID: 22364848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal akinesia sequence caused by glycogenosis type VII.
    Moerman P; Lammens M; Fryns JP; Lemmens F; Lauweryns JM
    Genet Couns; 1995; 6(1):15-20. PubMed ID: 7794557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular pathology and gene diagnosis of muscle glycogenosis].
    Suzuki Y
    Nihon Rinsho; 1997 Dec; 55(12):3302-6. PubMed ID: 9436455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased erythrocyte content of Ca2+ in patients with Tarui's disease.
    Waldenström A; Engström I; Ronquist G
    J Intern Med; 2001 Jan; 249(1):97-102. PubMed ID: 11168789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Muscle glycogenosis].
    Kono N; Itoh N
    Ryoikibetsu Shokogun Shirizu; 1997; (17 Pt 2):273-6. PubMed ID: 9277915
    [No Abstract]   [Full Text] [Related]  

  • 15. Type VII glycogenosis (muscle and erythrocyte phosphofructokinase deficiency).
    Tarui S; Kono N; Kuwajima M; Ikura Y
    Monogr Hum Genet; 1978; 9():42-7. PubMed ID: 153468
    [No Abstract]   [Full Text] [Related]  

  • 16. Phosphofructokinase deficiency and portal and mesenteric vein thrombosis.
    Madhoun MF; Maple JT; Comp PC
    Am J Med Sci; 2011 May; 341(5):417-9. PubMed ID: 21358310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary hyperuricemia in glycogen storage disease types I, III, V and VII].
    Yamasaki T; Mineo I
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():307-12. PubMed ID: 12629737
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII).
    Musumeci O; Bruno C; Mongini T; Rodolico C; Aguennouz M; Barca E; Amati A; Cassandrini D; Serlenga L; Vita G; Toscano A
    Neuromuscul Disord; 2012 Apr; 22(4):325-30. PubMed ID: 22133655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low glucose-1, 6-bisphosphate and high fructose-2, 6-bisphosphate concentrations in muscles of patients with glycogenosis types VII and V.
    Yamada Y; Kono N; Nakajima H; Shimizu T; Kiyokawa H; Kawachi M; Ono A; Nishimura T; Kuwajima M; Tarui S
    Biochem Biophys Res Commun; 1991 Apr; 176(1):7-10. PubMed ID: 2018547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile form of muscle phosphofructokinase deficiency in a premature neonate.
    Wu PL; Yang YN; Tey SL; Yang CH; Yang SN; Lin CS
    Pediatr Int; 2015 Aug; 57(4):746-9. PubMed ID: 26108272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.